Estimation of scopoletin from a polyherbal formulation composition using HPLC coupled with fluorescence detector through the concept of Design of Experiment

High-performance liquid chromatography (HPLC) coupled with a fluorescence detector was used to analyse bioactive phytoconstituent scopoletin from a polyherbal composition derived from the extract prepared from roots of Argyreia nervosa, roots of Withania somnifera, and fruits of Tribulus terrestris. This analytical method was developed as a quality control tool for standardization of the composition to be formulated to enhance spermatogenesis. Chromatographic separation was achieved using Luna® (250 mm × 4.6 mm, 100 Å, 5 μm) C₁₈ column as a stationary phase, and water (0.01 M glacial acetic acid):methanol: acetonitrile (60:20:20, %v/v/v) as the mobile phase; passed through the column at a set flow rate of 1.0 ml min⁻¹. The elute in the flow cell was excited at 345 nm and the chromatogram was recorded at 444 nm as the emission wavelength. As a part of the analytical Quality by Design approach, systemic studies were conducted to identify potential risks affecting the critical attributes (area, resolution, retention time) of the analytical method, and mitigating the potential risks after optimizing the chromatographic parameters with the help of the Design of Experiment approach. The developed analytical method was subjected to the validation studies, which showed a linear relationship (r² = 0.9982) between the concentration and the area corresponding to scopoletin peak in the concentration range 10–130 ng ml⁻¹. The method was found selective, sensitive, and precise. The recovery of the scopoletin was found in a range 99.53–102.13%; confirming the accuracy of the analytical method. The amount of scopoletin was estimated to be 0.146%w/w from the polyherbal composition.     

Specific and nonspecific infiltration of sponge matrix allografts by specifically sensitized cytotoxic lymphocytes

Urethane sponges coated with allogeneic or syngeneic cells were implanted subcutaneously into mice and the cytotoxicity of infiltrating host cells was assessed in vitro. First-set allogeneic sponges attracted a population of lymphocytes enriched in cytotoxic T cells directed against the alloantigens in the sponge. If two sponges bearing cells of different H-2 specificity were grafted simultaneously to a single recipient, specifically sensitized cytotoxic cells (SSCL) were found in both sponges directed against both sets of alloantigens, although specific infiltration predominated. If a syngeneic and allogeneic sponge were transplanted, SSCL were found in both the syngeneic sponge and allogeneic sponge. These data are interpreted to suggest that chemotactic substances are elaborated at graft sites which can attract circulating SSCL into sites of inflammation and that those released at the specific site are more attractive for SSCL than are those elaborated at sites of nonspecific rejection or healing. In recipients who had previously been sensitized to alloantigens, second-set grafts were rapidly infiltrated by SSCL directed against the sensitizing antigen. First-set indifferent allografts in sensitized recipients were infiltrated by SSCL directed against the previous alloantigens as well as SSCL directed against its own alloantigens. Syngeneic grafts were not infiltrated by SSCL in presensitized recipients. These data suggest that any alloantigenic stimulus can induce the mobilization from lymphoid depots of preformed SSCL directed against another set of antigens; syngeneic grafts cannot. Once mobilized, however, circulating SSCL can respond to specific and nonspecific chemotactic factors elaborated by either healing or rejecting grafts.